Adrenaline auto injectors pharmacokinetic/pharmacodynamic studies and potential consequences for clinical practice.

"CONFLICT OF INTEREST STATEMENT MWo has received financial grants from ALK‐Abelló Arneimittel, Mylan Germany GmbH. AF received consultation fees for his trust from Viatris. No personal fee was involved. MWi has been a paid instructor and has received speaker fees for MEDA and Mylan. JR serves as a consultant for Viatris and has received speaker fees from Galderma, Viatris, Bencard, Sanofi and AbbVie. ME has received speaker fees from Mylan and DBV Technologies. GP has received consultation fees from Bausch and Lomb, Viatris, BioProject, and speaker fees from Bausch and Lomb, AI therapeutics, BioProject and Viatris. PS received financial grants from Mylan, GlaxoSmithKline, and Sanofi for being a part of investigator‐initiated studies and has received consultation fees from Sequirus, AstraZeneca, Novartis and Viatris (for being a part of advisory board)."

"Under the guidance of the authors, the writing assistance for this manuscript was provided by Akshata Rao, Shazia Khanam, PhD, and Gaurav Anand (all employed with Tata Consultancy Services). The review and coordination support were provided by Dr. Ferdinand Kopietz (employed with Viatris). The assistance was funded by Viatris. Open Access funding enabled and organized by Projekt DEAL."